MD: IL-33 inhibition with tozorakimab may offer clinical benefits in patients with COPD at high risk of exacerbations.

Ultra-fine dust (PM2.5) is a fine particle of 2.5㎛ or less, absorbed directly into the body without passing through the nose ...

The new device has been described as 'the first real breakthrough in decades' for one of the 'most underdiagnosed conditions' ...

The device, known as N-Tidal Diagnose, uses carbon dioxide sensors to measure changes in a patient’s lung function with results given in minutes.

A revolutionary AI-powered diagnostic test for chronic obstructive pulmonary disease (COPD) is set to be introduced in GP ...

Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...

The global airway clearance devices system market is set to witness significant growth, with a compound annual growth rate ...

Dr. Chengfeng Fu, a lung specialist from Chongqing, China, led the study. He said, “Our study demonstrated an increased risk of all-cause and cardiovascular disease mortality in people who had COPD ...

A total of 5,039 eligible patients (3,559 commercial, 347 Medicaid, and 1,403 Medicare) with a new diagnosis of COPD during the study period were identified ( Table 1). Sixty-five percent of ...

“Chronic fatigue syndrome, also known as myalgic encephalomyelitis (ME), is a complex and debilitating condition that is characterised by persistent, unexplained fatigue that does not improve ...

HONEY BROOK, Pennsylvania (WPVI) -- Many people with COPD have other chronic conditions, too. Treating those multiple conditions can take careful coordination. In diabetes, a new generation of ...

COPD is an inflammatory lung disease, comprising several conditions, including chronic bronchitis and emphysema, and can be caused by genetics and irritants like smoke or pollution. The disease ...